157 related articles for article (PubMed ID: 19804473)
1. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE
Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
Anneser JM; Chahli C; Borasio GD
Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
[TBL] [Abstract][Full Text] [Related]
4. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
Perry TL; Krieger C; Hansen S; Eisen A
Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
[TBL] [Abstract][Full Text] [Related]
6. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole.
Yáñez M; Galán L; Matías-Guiu J; Vela A; Guerrero A; García AG
Brain Res; 2011 Nov; 1423():77-86. PubMed ID: 21983205
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid from amyotrophic lateral sclerosis has no effect on intracellular free calcium in cultured cortical neurons.
Gredal O; Witt MR; Dekermendjian K; Møller SE; Nielsen M
Mol Chem Neuropathol; 1996; 29(2-3):141-52. PubMed ID: 8971692
[TBL] [Abstract][Full Text] [Related]
8. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line.
Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Subramaniam JR; Nalini A; Raju TR
Brain Res; 2009 Mar; 1263():122-33. PubMed ID: 19368830
[TBL] [Abstract][Full Text] [Related]
10. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
[TBL] [Abstract][Full Text] [Related]
11. Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Sankaranarayani R; Nalini A; Rao Laxmi T; Raju TR
Behav Brain Res; 2010 Jan; 206(1):109-19. PubMed ID: 19747511
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
14. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
[TBL] [Abstract][Full Text] [Related]
15. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis.
Murata T; Ohtsuka C; Terayama Y
Free Radic Res; 2008 Mar; 42(3):221-5. PubMed ID: 18344116
[TBL] [Abstract][Full Text] [Related]
16. Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis.
Gomez-Pinedo U; Yáñez M; Matías-Guiu J; Galán L; Guerrero-Sola A; Benito-Martin MS; Vela A; Arranz-Tagarro JA; García AG
Neurologia; 2014; 29(6):346-52. PubMed ID: 24144827
[TBL] [Abstract][Full Text] [Related]
17. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
18. Cerebral magnetic resonance imaging pathology and cerebro-spinal fluid protein in sporadic amyotrophic lateral sclerosis (sALS).
Westarp ME; Schreiber H; Westarp MP; Westphal KP; Mauch E; Kornhuber HH
Clin Neuropathol; 1995; 14(4):228-32. PubMed ID: 8521627
[TBL] [Abstract][Full Text] [Related]
19. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ford L; Rowe D
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):118-20. PubMed ID: 15204013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
